Neuronetics (STIM) EBIT Growth (1y) (2018 - 2026)
Neuronetics (STIM) EBIT Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 90.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 74.18% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -18.12% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neuronetics | 130.83 Mn | 128.62 Mn | 16.15 Mn | 18.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.33% |
| Dec 31, 2025 | 56.04% |
| Sep 30, 2025 | 5.27% |
| Jun 30, 2025 | 5.28% |
| Mar 31, 2025 | -60.58% |
| Dec 31, 2024 | -159.14% |
| Sep 30, 2024 | 12.88% |
| Jun 30, 2024 | -15.76% |
| Mar 31, 2024 | 30.77% |
| Dec 31, 2023 | 42.71% |
| Sep 30, 2023 | -19.01% |
| Jun 30, 2023 | 24.98% |
| Mar 31, 2023 | 2.25% |
| Dec 31, 2022 | -11.84% |
| Sep 30, 2022 | -3.79% |
| Jun 30, 2022 | -49.24% |
| Mar 31, 2022 | -46.69% |
| Dec 31, 2021 | -159.74% |
| Sep 30, 2021 | -196.29% |
| Jun 30, 2021 | 4.30% |